articleCapital Raising
Biotech Pre-Seed Funding: How FDA Regulatory Pathways Shape Your Capital Strategy
Biotech fundraising is shaped by FDA regulatory requirements, not growth potential. Your capital target and timeline are determined by regulatory pathway: diagnostics (12-18 months), therapeutics (24-36+ months), or devices (18-24 months).
ByRachel Vasquez
·14 min read
Biotech fundraising is shaped by FDA regulatory requirements, not growth potential. Your capital target and timeline are determined by regulatory pathway: diagnostics (12-18 months), therapeutics (24-36+ months), or devices (18-24 months).
Looking for investors?
Browse our directory of 750+ angel investor groups, VCs, and accelerators across the United States.
Share
R
About the Author
Rachel Vasquez